Jennison Associates’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding TRVI
Jennison Associates's TRVI Position: Q3 2026 in Review
Jennison Associates opened a new position in Trevi Therapeutics (TRVI) in Q3 2026: 416,089 shares worth $5.96M. The stake represents ﹤0.01% of the portfolio and ranks #421 among its holdings.
223 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.
- Jennison Associates held 416,089 shares of Trevi Therapeutics worth $5.96M as of Q3 2026.
- Trevi Therapeutics was a new Jennison Associates position in Q3 2026.
- Trevi Therapeutics made up ﹤0.01% of Jennison Associates's portfolio in Q3 2026, its #421 holding.
- 223 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.
Based on Jennison Associates's 13F filing for Q3 2026, filed 16 Nov 2026.